Posted in | News | Imaging

Novel Imaging Software can Diagnose Jaundice in the Blink of an Eye

Imagine a system that can detect within one second whether a newborn baby has jaundice, a condition affecting 60 per cent of infants, and in severe cases leading to brain damage and hearing loss.

Visualise that system kickstarting a treatment regime immediately and notifying a nurse by text message.

Thanks to researchers from Iraq and Adelaide, all three scenarios are now possible.

Engineers from the University of South Australia and Middle Technical University have designed imaging software that can accurately diagnose jaundice in the blink of an eye, automatically turn on a blue LED light to counteract it and send the diagnosis in an SMS to the carer.

Jaundice is a common condition in newborns, especially premature babies, where there is an overload of an orange-yellow pigment called bilirubin in the bloodstream. It normally resolves quickly when the baby's liver is mature enough to remove it from the body.

However, in severe cases of jaundice, caused by sickle cell anaemia, blood disorders and lack of certain enzymes, phototherapy is normally used to treat the condition, using fluorescent blue light to break down the bilirubin in the baby's skin.

UniSA remote sensing engineer Professor Javaan Chahl says jaundice is particularly prevalent in developing countries where there often isn't the equipment or trained medical staff to effectively treat it.

"Using image processing techniques extracted from data captured by the camera, we can cheaply and accurately screen newborns for jaundice in a non-invasive way, before taking a blood test," Prof Chahl says.

"When the bilirubin levels reach a certain threshold, a microcontroller triggers blue LED phototherapy and sends details to a mobile phone.

"This can be done in one second, literally, which can make all the difference in severe cases, where brain damage and hearing loss can result if treatment is not administered quickly."

Researchers tested the system in an intensive care unit in Mosul, Iraq, on 20 newborns diagnosed with jaundice. A second data set captured 16 images of newborns, five of whom were healthy, and the remainder jaundiced. The system was also successfully tested on four other manikins with white and brown skin colours, with and without jaundice pigmentation.

"Previous research using sensors to find a non-invasive way to detect jaundice has fallen short. Methods trialled have been unreliable, costly, inefficient and in some cases caused infections and allergies where sensors needed skin contact," Prof Chahl says.

"Our system overcomes these obstacles by immediately detecting jaundice based on a novel digital representation of colour which allows high diagnostic accuracy at a relatively low cost. It could be widely used in hospitals worldwide and medical centres where laboratory facilities and trained medical staff are not available."

The study has been published in engineering journal Designs. For a copy of the paper email [email protected]

Notes for editors

"Neonatal jaundice detection using a computer vision system" is authored by Prof Javaan Chahl, Joint Chair of Sensor Systems at UniSA and the Defence Science and Technology Group, and Iraqi researchers Ms Warqaa Hashim, Dr Ali Al-Naji, Dr Izzat A. Al-Rayahi, and Dr Makram Alkhaled.

Newborn jaundice occurs in up to 85 per cent of all live births, including premature babies. It usually resolves within 3-5 days without significant complications, but can lead to thousands of infant deaths, particularly in Africa and Southeast Asia, where treatment options are limited. A 2018 paper estimated that 75,000 children are living with brain dysfunction worldwide due to complications from jaundice.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.